ReachMD

Be part of the knowledge.™

Nephrology

192

LikeLikedUnlike

Episodes 1-15 of 34

- Mikhail Kosiborod, MD
  Peer
- Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
  Peer
12
CME/CE
New Perspectives in Managing HF and HK – The Cardiorenal Angle
New Perspectives in Managing HF and HK – The Cardiorenal Angle
0.25 credits
- Eugene E. Wright, Jr., MD
  Peer
- Jolanta Małyszko, MD, PhD
  Peer
- María José Soler, MD, PhD
  Peer
7
CME/CE
Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D
Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D
0.25 credits
- Josep Comin-Colet, MD, PhD
  Peer
10
CME/CE
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Stefan D. Anker, MD, PhD
  Peer
17
CME/CE
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
0.25 credits
- Peter Rossing, DMSc, MD
  Peer
- Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
  Peer
- Matthew R. Weir, MD
  Peer
10
CME/CE
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
0.25 credits
- Murray Epstein, MD
  Peer
- Gates B. Colbert, MD, FASN
  Peer
1
CME/CE
Considerations When Using a Potassium Binder in Patients with CKD
Considerations When Using a Potassium Binder in Patients with CKD
0.25 credits
- Peter van der Meer, MD, PhD
  Peer
- Pieter Martens, MD, PhD
  Peer
8
CME/CE
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling
0.25 credits
- George L. Bakris, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
3
CME/CE
Optimizing RAASi Therapy: The Role of Personalized Medicine
Optimizing RAASi Therapy: The Role of Personalized Medicine
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Marco Metra, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
6
CME/CE
The Future of Heart Failure Management: Rethinking Approaches to Care
The Future of Heart Failure Management: Rethinking Approaches to Care
0.50 credits
- Mikhail Kosiborod, MD
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Matthew R. Weir, MD
  Peer
5
CME/CE
Synergy of Guideline-Directed Medical Therapies in Heart Failure to Optimize Patient Outcomes
Synergy of Guideline-Directed Medical Therapies in Heart Failure to Optimize Patient Outcomes
0.50 credits
- Gregg C. Fonarow, MD
  Peer
- Andrew J. S. Coats, MD
  Peer
5
CME/CE
Applying Key Updates from ESC/HFA to Managing Heart Failure
Applying Key Updates from ESC/HFA to Managing Heart Failure
0.25 credits
- Keith C. Ferdinand, MD
  Peer
- Marco Metra, MD
  Peer
9
CME/CE
Managing HK in HF: Navigating the Evolving Clinical Landscape
Managing HK in HF: Navigating the Evolving Clinical Landscape
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Phil McEwan, PhD
  Peer
4
CME/CE
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
0.25 credits
- Steven Fishbane, MD
  Peer
- Shayan Shirazian, MD
  Peer
- Jennifer Caudle, DO
  Peer
2
CME/CE
Real-World Cases: The Itch Clinic: Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients
Real-World Cases: The Itch Clinic: Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients
0.50 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
5
CME/CE
From Guidelines to Practice: Key Updates From 2021 HFSA
From Guidelines to Practice: Key Updates From 2021 HFSA
0.25 credits

Segment Chapters

Playlist:

Recommended

Webpack App